ES548667A0 - Un procedimiento para la preparacion de polipeptidos. - Google Patents

Un procedimiento para la preparacion de polipeptidos.

Info

Publication number
ES548667A0
ES548667A0 ES548667A ES548667A ES548667A0 ES 548667 A0 ES548667 A0 ES 548667A0 ES 548667 A ES548667 A ES 548667A ES 548667 A ES548667 A ES 548667A ES 548667 A0 ES548667 A0 ES 548667A0
Authority
ES
Spain
Prior art keywords
polypeptides
procedure
preparation
same
novel polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548667A
Other languages
English (en)
Other versions
ES8800272A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES8800272A1 publication Critical patent/ES8800272A1/es
Publication of ES548667A0 publication Critical patent/ES548667A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES548667A 1984-11-09 1985-11-07 Un procedimiento para la preparacion de polipeptidos. Expired ES8800272A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59236076A JPH0680079B2 (ja) 1984-11-09 1984-11-09 ポリペプチド

Publications (2)

Publication Number Publication Date
ES8800272A1 ES8800272A1 (es) 1987-10-16
ES548667A0 true ES548667A0 (es) 1987-10-16

Family

ID=16995360

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548667A Expired ES8800272A1 (es) 1984-11-09 1985-11-07 Un procedimiento para la preparacion de polipeptidos.

Country Status (21)

Country Link
US (1) US4707468A (es)
EP (2) EP0181001B1 (es)
JP (1) JPH0680079B2 (es)
KR (1) KR880000765B1 (es)
CN (1) CN1029684C (es)
AT (1) ATE135712T1 (es)
AU (1) AU588837B2 (es)
CA (1) CA1267997A (es)
DE (1) DE3588095T2 (es)
DK (1) DK171300B1 (es)
ES (1) ES8800272A1 (es)
FI (1) FI92935C (es)
GR (1) GR852689B (es)
HU (1) HU203563B (es)
IL (1) IL76924A (es)
NO (1) NO169347C (es)
NZ (1) NZ214122A (es)
PH (1) PH23847A (es)
PT (1) PT81441B (es)
SU (1) SU1433415A3 (es)
ZA (1) ZA858456B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673376A1 (fr) * 1991-03-01 1992-09-04 Lefesvre Andre Composition pharmaceutique pour le traitement des tumeurs de kaposi.
US5817628A (en) * 1992-12-02 1998-10-06 The Rockefeller University Dynorphin a suppression of natural killer cell activity
SE9401596D0 (sv) * 1994-05-06 1994-05-06 Astra Ab New compounds
JP3385147B2 (ja) * 1996-01-31 2003-03-10 ユニ・チャーム株式会社 男性用尿とり袋
WO1997049422A1 (en) * 1996-06-24 1997-12-31 The Rockefeller University Method of using ligands of the kappa opioid receptor
AU757658B2 (en) * 1998-03-09 2003-02-27 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CA2419285C (en) * 2000-08-25 2011-08-02 Research Corporation Technologies, Inc. New uses for amino acid anticonvulsants
ATE327744T1 (de) * 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz
DE60100055T2 (de) * 2001-03-21 2003-07-24 Schwarz Pharma Ag Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
US7491702B2 (en) * 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
KR20070007931A (ko) 2004-04-16 2007-01-16 쉬바르츠파르마에이지 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도
PL1781276T3 (pl) * 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
GB2432586B (en) * 2005-11-25 2010-01-13 Univ Open Treatment of neurodegenerative disorders
EA019757B1 (ru) 2006-06-15 2014-06-30 ЮСиБи ФАРМА ГМБХ Фармацевтическая композиция с синергетическим противосудорожным эффектом
KR20100057063A (ko) * 2007-09-11 2010-05-28 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드의 용도
KR20100059863A (ko) * 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 티모신 베타 ４ 단독 또는 세크로핀 ａ와의 배합물의 용도
JP6901801B2 (ja) * 2017-06-14 2021-07-14 バイオソリューション カンパニー・リミテッドＢｉｏ Ｓｏｌｕｔｉｏｎ Ｃｏ Ｌｔｄ 物質ｐを含むしわの改善または抗炎症化粧料組成物
EP3681900A4 (en) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. OPIOID AGONIST PEPTIDES AND THEIR USES
US20240301023A1 (en) * 2020-07-01 2024-09-12 PreveCeutical Medical Inc. Peptides and uses thereof
RU2760133C1 (ru) * 2021-04-22 2021-11-22 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства". Амиды гептапептида для лечения HMGB1-зависимых заболеваний
CA3238696A1 (en) * 2021-11-18 2023-05-25 PreveCeutical Medical Inc. Peptides and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254106A (en) * 1976-01-26 1981-03-03 Burroughs Wellcome Co. Biologically active amides
IL51332A (en) * 1976-01-26 1980-09-16 Wellcome Found Peptides having a morphine-like effect, their preparation and pharmalceutical compositions containing them
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4081434A (en) * 1977-03-11 1978-03-28 Hoffmann-La Roche Inc. Novel analogs of β-endorphin
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
US4178284A (en) * 1978-12-11 1979-12-11 American Home Products Corporation Octapeptides
DE2936099A1 (de) * 1979-09-06 1981-04-02 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive peptide
DE3163199D1 (en) * 1980-07-17 1984-05-24 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
JPS57134451A (en) * 1981-02-13 1982-08-19 Suntory Ltd Peptide opioide
EP0076676B1 (en) * 1981-10-05 1986-12-30 Tni Pharmaceuticals, Inc. Process for using endorphins as antitumour agents
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
JPS59141547A (ja) * 1983-02-01 1984-08-14 Eisai Co Ltd 鎮痛作用を有する新規ペプタイドおよび製法
US4518711A (en) * 1983-05-16 1985-05-21 Gibson-Stephens Institute Conformationally constrained cyclic enkephalin analogs with delta receptor specificity

Also Published As

Publication number Publication date
KR880000765B1 (en) 1988-05-06
NO169347B (no) 1992-03-02
PT81441B (pt) 1987-11-11
SU1433415A3 (ru) 1988-10-23
US4707468A (en) 1987-11-17
DK513385A (da) 1986-05-10
NZ214122A (en) 1988-08-30
GR852689B (es) 1986-02-21
EP0181001A3 (en) 1989-04-19
PH23847A (en) 1989-11-23
EP0614913A3 (en) 1997-06-04
FI854227A0 (fi) 1985-10-28
DE3588095D1 (de) 1996-04-25
AU588837B2 (en) 1989-09-28
CA1267997A (en) 1990-04-17
FI92935C (fi) 1995-01-25
EP0181001A2 (en) 1986-05-14
KR860004081A (ko) 1986-06-16
FI854227L (fi) 1986-05-10
HUT40145A (en) 1986-11-28
JPH0680079B2 (ja) 1994-10-12
CN85109722A (zh) 1986-10-08
JPS61115097A (ja) 1986-06-02
DK171300B1 (da) 1996-08-26
DK513385D0 (da) 1985-11-07
PT81441A (en) 1985-12-01
IL76924A (en) 1990-07-12
AU4938985A (en) 1986-05-15
IL76924A0 (en) 1986-04-29
FI92935B (fi) 1994-10-14
NO854435L (no) 1986-05-12
EP0181001B1 (en) 1996-03-20
DE3588095T2 (de) 1996-09-19
NO169347C (no) 1992-06-10
ES8800272A1 (es) 1987-10-16
HU203563B (en) 1991-08-28
CN1029684C (zh) 1995-09-06
ATE135712T1 (de) 1996-04-15
ZA858456B (en) 1987-07-29
EP0614913A2 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
AU588837B2 (en) Polypeptide
FI874570A0 (fi) Antibakteriska medel -ii.
ES8502105A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
EP0027908A3 (en) 2-hydroxyalkyl-3,4,5,trihydroxy piperidines, processes for their preparation and their use as medicaments
ES554636A0 (es) Un procedimiento para preparar derivados de vinilisoquinolina
AU557494B2 (en) 2-substituted-5-arylimidazoles
DK16985A (da) Leukotrienantagonister samt fremgangsmaade til fremstilling heraf
KR950013453B1 (en) Composition containing 15-deoxisper gualine
AU562271B2 (en) Pharmaceutical composition of corazepam and diphenhydramine
EP0241292A3 (en) 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates
DE3560483D1 (en) Derivative of p-aminophenol with a mucosecretolytic fluidizing and antipyretic activity, process for its preparation and pharmaceutical compositions thereof
ES540693A0 (es) Un procedimiento de preparar sales quinato de alfa-2-piperi-dinil-2,8-bis(trifluorometil)-4-quinolino-metanol
DE69002027D1 (de) (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid.